Cytokines released by infiltrating inflammatory cells around the pancreatic islets are involved in the pathogenesis of type 1 diabetes. Interleukin (IL)-1ß and interferon (IFN)-Á are the primary cytokines responsible for stimulation of inducible nitric oxide synthase (iNOS) expression and nitric oxide overproduction, which leads to ß-cell damage. In addition, nuclear factor-κB (NF-κB) plays a crucial role in the activation of this pathway. Therefore, suppression of the cytokine-NF-κB pathway is considered an effective therapeutic strategy for preventing inflammatory reactions in pancreatic ß-cells. In this study, the effects of Fructus Xanthii extract (FXE) on IL-1ß and IFN-Á-induced ß-cell damage were examined. Treatment of RINm5F cells with IL-1ß and IFN-Á reduced cell viability, however, FXE completely protected cells from IL-1ß and IFN-Á-mediated reduction in viability in a concentrationdependent manner. In addition, incubation with FXE resulted in a significant suppression of IL-1ß and IFN-Á-induced nitric oxide (NO) production, which correlated with the reduced levels of the inducible form of iNOS mRNA and protein observed. The IL-1ß and IFN-Á-stimulated RIN cells showed increases in NF-κB binding activity and p50 subunit levels in the nucleus, as well as increased IκB· degradation in cytosol when compared to unstimulated cells, which indicates that the mechanism by which FXE inhibited the iNOS gene involves inhibition of NF-κB activation. Furthermore, a protective effect of FXE was demonstrated by reduction in NO generation and iNOS expression, as well as the normal insulin secreting responses to glucose observed in IL-1ß and IFN-Á-treated islets.
Introduction
Autoimmune insulitis, which is the infiltration of inflammatory cells within and around the pancreatic islets, is the primary characteristic of type 1 (insulin-dependent) diabetes (1) . In this process, proinflammatory agents, such as cytokines and free radicals, are released from the infiltrated inflammatory cells. It was previously reported that interleukin (IL)-1ß, either alone or in combination with tumor necrosis factor-· or interferon (IFN)-Á, induces the expression of inducible nitric oxide synthase (iNOS) in ß-cells, which leads to overproduction of nitric oxide (NO) that mediates the inhibition of insulin secretion and cytotoxicity of ß-cells (2) (3) (4) (5) . This time-dependent inhibitory action of IL-1ß on islet function correlates with the timedependent expression of iNOS and the production of nitric oxide (NO) (6) . NO is a short-lived and highly reactive radical that inhibits the Krebs-cycle enzyme aconitase and the electron transport chain complexes I and II, thereby leading to decreased glucose oxidation rates, ATP generation and insulin production (7) (8) (9) . iNOS inhibitors, such as N w -nitro-L-arginine methylester (L-NAME) and aminoguanidine, prevent the inhibitory actions of IL-1ß on islet oxidative metabolism and secretory function (10) . Although IFN-Á alone does not stimulate iNOS expression in rat islets, it does prime them for IL-1ß-induced iNOS expression (11) .
The inhibitory actions of IL-1ß on islets are associated with the expression of various genes activated by nuclear factor-κB (NF-κB), a transcription factor. The long exposure of islets to IL-1ß stimulates various NF-κB-mediated genes, including iNOS and cyclooxygenase-2 (5,12), however, phosphorylation and proteolytic degradation of IκB is required for NF-κB activation to occur. NF-κB is initially located in the cytosol complexed with IκB in an inactive form. Various inducers cause dissociation of this complex, presumably via phosphorylation of IκB, which causes NF-κB to be released from the complex. NF-κB then translocates to the nucleus, where it interacts with specific DNA recognition sites to mediate gene transcription (13) (14) (15) Fructus Xanthii, which is the fruit of Xanthium strumarium L. and belongs to the Compositae family, is known to clear the nasal passages and alleviate symptoms of the common cold. To our knowledge, however, the antidiabetic effects of FXE have not yet been reported. Therefore, this study was conducted to investigate the effect of FXE on IL-1ß and IFN-Á-induced ß-cell damage, with a focus on the effect of FXE on iNOS expression. The results of this study show that FXE inhibited IL-1ß and IFN-Á-induced NF-κB activation, iNOS expression, NO production, glucose-stimulated insulin secretion (GSIS) and cell death in ß-cells, which may explain the beneficial effects of FXE as an anti-diabetic agent.
Materials and methods
Cell culture and reagents. RINm5F (RIN) cells were purchased from the American Type Culture Collection and grown at 37˚C under a humidified, 5% CO 2 atmosphere in RPMI-1640 medium (Gibco BRL, Grand Island, NY) supplemented with 10% fetal bovine serum, 2 mM glutamine, 100 U/ml of penicillin, 100 μg/ml of streptomycin, and 2.5 μg/ml of amphotericin B. IL-1ß and IFN-Á were obtained from R&D (Minneapolis, MN). All reagents were purchased from Sigma (St. Louis, MO) unless otherwise noted.
Preparation of Fructus Xanthii extract.
The plant was purchased from Wonkwang Oriental Medical Hospital in Iksan, Jeonbuk, Korea and identified as Fructus Xanthii by Ho-Joon Song, keeper of the Herbarium. Voucher samples were preserved for reference in the Herbarium of the Department of Physiology, School of Oriental Medicine, Wonkwang University. For extraction, 200 g of Fructus Xanthii were ground and extracted in boiling water for 4 h. The sample was then centrifuged at 3,000 x g for 20 min, after which the supernatant was concentrated under reduced pressure to 200 ml and then freeze dried to 18.24 g. The sterile extract was stored at -70˚C.
MTT assay for cell viability. The viability of cultured cells was determined by assaying the reduction of 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) to formazan. Briefly, RIN cells were seeded overnight in 96-well tissue culture plates with clear, flat bottoms (Becton-Dickinson, Franklin Lakes, NJ) at a density of 1x10 5 cells per well in 100 μl of medium. Cells were then pretreated with various concentrations of FXE or 1 mM L-NAME for 3 h, and then IL-1ß (2 ng/ml) and IFN-Á (100 U/ml) were added for an additional 48 h. Next, cells were washed twice with PBS, after which MTT (100 μg/100 μl of PBS) was added. Next, the cells were incubated at 37˚C for 1 h, and then DMSO (100 μl) was added to dissolve the formazan crystals. The absorbance at 570 nm was then measured using a model Spectra MAX PLUS spectrophotometer (Molecular Devices, Sunnyvale, CA).
5-Bromo-2-deoxyuridine (BrdU)-labeling cell proliferation assay.
A cell proliferation enzyme-linked immunosorbant assay (BrdU kit, Amersham Biosciences, Piscataway, NJ) was used to measure the incorporation of BrdU during DNA synthesis following the manufacturer's protocols. Briefly, RIN cells (1x10 5 ) were pretreated with the indicated concentrations of FXE or 1 mM L-NAME for 3 h, after which IL-1ß (2 ng/ml) and IFN-Á (100 U/ml) were added. Following 48 h of incubation, BrdU (10 μM) was added to the culture medium for 2 h, after which BrdU-labeled cells were fixed. The DNA was then denatured in fixative solution for 30 min at room temperature, followed by incubation of cells with peroxidaseconjugated anti-BrdU antibody for 2 h at room temperature. Cells were then washed three times with washing solution, after which the immune complex was detected using a 3,3',5,5'-tetramethylbenzidine substrate reaction and the absorbance was measured at 405 nm using a Spectra MAX PLUS spectrophotometer.
Nitrite measurement. Biologically produced NO is rapidly oxidized to nitrite and nitrate in aqueous solutions. Therefore, NO production was evaluated by measuring nitrite concentrations in the cell-free culture supernatant using a colorimetric assay. Briefly, RIN cells ( 5x10 5 ) were pretreated with the indicated concentrations of FXE for 3 h, and then IL-1ß (2 ng/ml) and IFN-Á (100 U/ml) were added. Following 24 h of incubation, 100 μl aliquots of the culture supernatants were incubated with 100 μl of a modified Griess reagent (1:1 mixture of 1% sulfanilamide in 30% acetic acid and 0.1% N-(1-naphthyl) ethylenediamine dihydrochloride in 60% acetic acid) at room temperature for 5 min, at which time the absorbance at 540 nm was measured using a spectro-photometer (Ultrospec 2100 pro, Amersham Biosciences). The concentrations of NO were then determined using a linear standard curve generated from serial dilutions of sodium nitrite in working medium.
Isolation of islets.
Pancreatic islets were isolated from male Sprague-Dawley rats by collagenase digestion, as described previously (16) . Following isolation, the islets were cultured overnight in RPMI-1640 supplemented with 2 mM L-glutamine, 10% heat-inactivated fetal calf serum, 100 U/ml penicillin, and 100 μg/ml streptomycin in a humidified atmosphere containing 5% CO 2 at 37˚C. Prior to each experiment, islets were washed three times in RPMI-1640, counted, and then cultured overnight.
Glucose-stimulated insulin secretion assay. Islets were cultured for 24 h with IL-1ß and IFN-Á in the presence or absence of FXE. Next, the islets were washed three times in Krebs-Ringer bicarbonate buffer (25 mM Hepes, 115 mM NaCl, 24 mM NaHCO 3 , 5 mM KCl, 1 mM MgCl 2 , 2.5 mM CaCl 2 , and 0.1% bovine serum albumin, pH 7.4) containing 3 mM D-glucose, after which insulin secretion was measured by static incubation of the islets for 30 min in the presence of either 5.5 or 20 mM D-glucose. The insulin content of the medium was then determined by ELISA (Linco Research, St. Charles, MO).
Western blot analysis. Cells were homogenized in 100 μl of ice-cold lysis buffer (20 mM Hepes, pH 7.2, 1% Triton X-100, 10% glycerol, 1 mM phenylmethylsulfonyl fluoride (PMSF), 10 μg/ml leupeptin, 10 μg/ml aprotinin). The homogenates, which contained 20 μg of protein, were then separated by SDS-PAGE with 7.5% (for iNOS) or 12% resolving (for IκB·, p50, ß-actin, and PCNA) and 3% acrylamide stacking gels, and then transferred to nitrocellulose membranes. The blots were blocked with 2% bovine serum albumin and then incubated for 4 h with 1 μg/ml of primary antibody (Santa Cruz Biochemicals, Santa Cruz, CA) and then detected with horseradish peroxidase-conjugated IgG (Zymed, South San Francisco, CA).
RNA isolation and real-time PCR.
Total RNA was isolated from RIN cells or islets using Trizol reagent (Invitrogen, Carlsbad, CA). RNA was then precipitated with isopropanol and dissolved in DEPC-treated distilled water. Next, total RNA (2 μg) was treated with RNase-free DNase (Invitrogen), after which first-strand cDNA was generated using the random hexamer primer provided in the first-strand cDNA synthesis kit (Applied Biosystems, Foster City, CA). The following specific primers for iNOS (accession No. NM_012611) were designed using the primer express software (Applied Biosynthesis): iNOS, 5'-TGTGCTAATGCGGAAGGTCAT-3' (forward), and 5'-CGACTTTCCTGTCTCAGTAGCAAA-3' (reverse). The sequence for the control 18S ribosomal RNA was purchased from Applied Biosystems and used as the invariant control. The real-time PCR reaction, which was contained in a final volume of 10 μl, consisted of 10 ng of reverse transcribed total RNA, 167 nM of forward and reverse primers and 2 x PCR master mixture. PCR was conducted in 384-well plates using the ABI Prism 7900HT Sequence Detection System (Applied Biosystems). All reactions were conducted in triplicate.
Preparation of nuclear protein extracts. Cells were washed with PBS and then lysed in CytoBuster™ Protein Extraction Buffer (Novagen). Next, the lysate was centrifuged at 10,000 x g for 5 min at 4˚C, and the supernatant was then used as the whole cell protein extract. Cytoplasmic and nuclear extracts were prepared from RINm5F cells using the NE-PER ® Nuclear and Cytoplasmic Extraction Reagents (Pierce Biotechnology, Rockford, IL) according to the manufacturer's instructions.
Electrophoretic mobility shift assay (EMSA).
The activation of NF-κB was assayed by a gel mobility shift assay using nuclear extracts from control and treated cells. An oligonucleotide containing the κ-chain binding site (κB, 5'-CCGGTTAACA GAGGGGGCTTTCCGAG-3') was synthesized and used as a probe for the gel retardation assay. The two complementary strands were then annealed and labeled with [·-
32 P]dCTP. The labeled oligonucleotides (10,000 cpm), 10 μg of nuclear extracts, and binding buffer (10 mM Tris-HCl, pH 7.6, 500 mM KCl, 10 mM EDTA, 50% glycerol, 100 ng poly(dI·dC), 1 mM dithiothreitol) were then incubated for 30 min at room temperature in a final volume of 20 μl. Next, the reaction mixtures were analyzed by electrophoresis on 4% polyacrylamide gels in 0.5 x Tris-borate buffer. The gels were then dried and examined by autoradiography. Specific binding was controlled by competition with a 50-fold excess of cold κB oligonucleotide.
Statistical analysis. Statistical analysis of the data was performed using ANOVA and Duncan's test. Differences with a p<0.05 were considered statistically significant.
Results

Prevention of IL-1ß and IFN-Á-induced cell death by FXE.
RIN cells from a rat pancreatic ß-cell line were cultured to near confluence. Cells that were pretreated with or without FXE for 3 h were then exposed to IL-1ß (2 ng/ml) and IFN-Á (100 U/ml) for 48 h, at which time they were harvested and their viability assessed using an MTT assay. Treatment with IL-1ß and IFN-Á significantly reduced cell viability to 42.4±3.2% of the control (Fig. 1A) . Conversely, pretreatment with FXE increased viability of IL-1ß and IFN-Á-treated RIN cells in a concentration-dependent manner. The protective effect of FXE on IL-1ß and IFN-Á-induced cytotoxicity was further confirmed by measuring the BrdU incorporation in RIN cells. After incubation with cytokines for 48 h, the level of BrdU incorporation, and therefore proliferation, was reduced to 34.3±3.26% of the control levels (Fig. 1B) . Similar to the results of the MTT assay, pretreatment with FXE prevented the IL-1ß and IFN-Á-mediated decrease in proliferative potential. Viability was not affected when RIN cells were treated with FXE at any of the concentrations used (data not shown). (5, 6) . In this study, incubation of RIN cells with IL-1ß and IFN-Á for 24 h resulted in significant production of nitrite (a stable oxidized product of NO) by these cells. However, the presence of FXE significantly diminished the IL-1ß and IFN-Á-mediated 1x10 5 ) were pretreated with the indicated concentrations of FXE or L-NAME for 3 h, and then IL-1ß and IFN-Á were added for 48 h. The cell viability and proliferative potential were then determined using an MTT (A) and BrdU incorporation assay (B), respectively, as described in Materials and methods. Each value represents the mean ±SEM of three independent experiments. ** p<0.01 vs. untreated control; # p<0.05, ## p<0.01 vs. IL-1ß + IFN-Á.
Effect of FXE on IL-1ß and IFN-Á-induced NO production by RIN cells. It was reported that IL-1ß and IFN-Á-mediated destruction of ß-cells is caused by an increase of NO
nitrite production ( Fig. 2A) , and this reduction was well correlated with the lowered cytotoxicity of the cells (Fig. 1) .
To examine whether FXE inhibited NO production via suppression of iNOS gene expression, changes in the expression of iNOS mRNA and proteins were investigated by real-time PCR and Western blot analysis, respectively. iNOS mRNA and protein expression were markedly increased in cells treated with IL-1ß and IFN-Á, whereas cells pretreated with FXE showed suppressed expression of both the mRNA and protein levels of iNOS ( Fig. 2B and C) , and this occurred in a concentration-dependent manner. Furthermore, addition of L-NAME, an inhibitor of iNOS, completely prevented the IL-1ß and IFN-Á-induced cytotoxicity (Fig. 1) . These results indicate that the cytoprotective effect of FXE against IL-1ß and IFN-Á occurred due to suppression of iNOS expression.
Effect of FXE on IL-1ß and IFN-Á-induced NF-κB activation.
Because NF-κB is implicated in the transcriptional regulation of cytokine-induced iNOS expression, we studied the effect of FXE on IL-1ß and IFN-Á-stimulated translocation of NF-κB from the cytosolic compartment to the nucleus and on DNA binding in RIN cells. IL-1ß and IFN-Á-treated RIN cells showed increased binding activity of an NF-κB consensus sequence (Fig. 3A) , as well as increased p50 subunit levels in their nuclei (Fig. 3B ) when compared to unstimulated cells. Additionally, IL-1ß and IFN-Á-induced NF-κB activation was markedly suppressed by pretreatment with FXE, which suggests that FXE inhibits iNOS expression through the inhibition of NF-κB activation. The specificity of DNA-protein interactions for NF-κB was demonstrated by performing competition assays using a 50-fold excess of unlabeled oligonucleotide (Fig. 3A, lane 7) . We previously reported that IκB·, but not IκBß, was the major participant in IL-1ß and IFN-Á induced NF-κB activation (17) . Therefore, we investigated the alteration of IκB· levels in the cytosol fraction after IL-1ß and IFN-Á treatment (Fig. 3C) . IL-1ß and IFN-Á-treated RIN cells showed a decreased level of IκB· protein in the cytosol when compared to a similar fraction in the unstimulated cells, however, the increased IκB· degradation as a result of IL-1ß and IFN-Á treatment was markedly suppressed by treatment with FXE, and this effect occurred in a concentration-dependent manner.
Inhibition of IL-1ß and IFN-Á-induced NF-κB pathways by FXE in rat islets.
We assessed the preventive effects of FXE using rat pancreatic islets isolated from male Sprague-Dawley rats to support the physiological importance of the results obtained in the cell line studies. Incubation of the rat islets with cytokines for 24 h resulted in a 3.5-fold increase in NO production (Fig. 4A) . Additionally, real-time PCR and Western blotting data showed that iNOS mRNA and protein levels were markedly increased by IL-1ß and IFN-Á (Fig. 4B and C) . Similar to the results obtained using the RIN cells, pretreatment of the islets with FXE abolished the effects of IL-1ß and IFN-Á, and resulted in suppressed levels of NO production and iNOS expression that were similar to those of the control.
Preservation of GSIS by FXE in the presence of IL-1ß and IFN-Á.
Our results consistently showed a suppressive effect of FXE on IL-1ß and IFN-Á-induced NF-κB-regulated gene expression. To add functional data, we determined whether FXE also protects against cytokine-induced impairment of GSIS. After 24 h of exposure to IL-1ß and IFN-Á, the level of insulin secretion in response to 20 mM of glucose was determined. Control islets were found to secrete insulin at a concentration of 10.6±2.1 ng/ml, whereas insulin secretion from IL-1ß and IFN-Á-treated islets decreased significantly to 5.23±1.1 ng/ml (p<0.05) (Fig. 5) . However, pretreatment with FXE blocked the effect of the cytokines and restored islet cell insulin secretion to levels similar to that of the controls.
Discussion
In this study, we examined the preventive effects of FXE on IL-1ß and IFN-Á-induced ß-cell damage. The results of MTT and BrdU incorporation assays showed that rat insulinoma cells pretreated with FXE were resistant to cytokine-induced cytotoxicity. The protective actions of FXE on cellular metabolism are associated with an inability of ß-cells to express iNOS or produce NO in response to IL-1ß and IFN-Á. Because both IL-1ß and IFN-Á are important mediators of ß-cell death (18, 19) , it was proposed that cytokine-NF-κB is a critical pathway for ß-cell death in type 1 diabetes (20) . The results of this study demonstrate that FXE prevents IL-1ß and IFN-Á-induced NF-κB nuclear translocation. These findings indicate that FXE provides functional protection against the damaging effects of IL-1ß and IFN-Á by preventing NF-κB-activation.
It is well known that IL-1ß and IFN-Á induce iNOS expression and overproduction of NO, which in turn leads to the dysfunction and destruction of ß-cells (5, 6) . The RIN cell is comparable to primary ß-cells in the aspects of IL-1ß and IFN-Á-mediated NO production, iNOS expression, and cytotoxicity (21) . We observed that the responses of RIN cells to IL-1ß were similar to those of islets with respect to nitrite formation and iNOS protein expression, even though they lack the type 2 glucose transporter (22, 23) . This result suggests that RIN cells are an appropriate substitute for primary ß-cells.
Pretreatment with FXE inhibited iNOS mRNA expression induced by IL-1ß and IFN-Á, which implies that FXE regulates the expression of iNOS at the transcriptional level. NF-κB is the primary transcription factor in the regulation of iNOS expression (5) , and in this study, Western blot analysis showed that FXE inhibited IL-1ß and IFN-Á-induced nuclear translocation of the p50 NF-κB subunit. In addition, EMSA indicated that FXE inhibited IL-1ß and IFN-Á-induced NF-κB DNA binding activity. FXE prevented NF-κB activation through prevention of IκB degradation. It is also possible that FXE inhibits NF-κB activation through stimulation of IκB kinase. Regardless of the mechanism, however, the net result of each event is the sequestration of NF-κB in the cytoplasm and inhibition of the subsequent NF-κB-dependent mRNA transcription, including the transcription of iNOS. Excessive NO production by overexpressed iNOS genes was reported in acute and chronic disease states, including type 1 diabetes (24,25). Currently, it is important to conduct studies that focus on the repression of NF-κB or its downstream events to protect ß-cells from various kinds of insults. We already reported the protective effect of a variety of natural compounds and herbs against cytokine-induced ß-cell damage through suppression of NF-κB activation (22, (26) (27) (28) , and many other studies were conducted in an attempt to save ß-cells from cytokine or cytotoxin-induced damage by repressing either NF-κB activation or NF-κB dependent gene expression (29) (30) (31) . However, in addition to iNOS, heat shock protein 70, heme oxygenase, Mn-superoxide dismutase (32) and cyclooxygenase-2 (33, 34) are also induced by NF-κB activation, all of which are stress response proteins known to be induced by cytokines, heat shock and oxidative stress. Therefore, we cannot exclude the possibility that FXE exerts a protective effect against cytokines through regulation of the aforementioned proteins. Traditional plant medicines have been used for centuries in different regions of the world. Despite insufficient evidence to support its therapeutic efficacy, the use of herbal medicine has increased considerably due to the relatively non-toxic effects, low cost and availability of these treatments (35, 36) . Fructus Xanthii, which is commonly used in Chinese medicine, was reported to have inhibitory effects on mast cell-mediated allergic reaction (37) , as well as anti-inflammatory actions in lipopolysaccharide-stimulated inflammatory responses (38) . To our knowledge, no other studies were conducted to evaluate the relationship of FXE with the prevention of ß-cell damage in type 1 diabetes. Therefore, in this study, we focused on the effects of FXE on cytokine-induced ß-cell damage using an insulinoma cell line and isolated pancreatic islets with the objective of elucidating the signaling mechanism through which they exert their effects. FXE rescued ß-cells from cytokine toxicity, reversed impairment, and completely restored function by suppressing the NF-κB pathway. Taken together, our data suggest a possible role of Fructus Xanthii as a preventive or therapeutic agent against type 1 diabetes.
